Description
About Apheris At Apheris, we are building the future of how AI is applied in pharmaceutical R&D. We enable leading pharmaceutical teams to discover and develop drugs faster. We host the industry’s largest federated data networks for drug discovery AI, spanning co-folding, ADMET, and antibody developability.
Across these networks, models are trained on proprietary industry datasets to achieve higher performance and broader applicability while keeping data control and IP protected. We deliver these superior models through drug discovery applications that enable teams to run them at scale, further customize them, and integrate them into existing R&D workflows. AI Structural Biology (AISB) Network: Pharmaceutical companies collaborate in the field of co-folding, structure-based binding affinity predictions and antibody design.
ADMET Network: Pharmaceutical and biotech companies collaborate to improve small-molecule property prediction and expand into further drug modalities. Antibody Developability Network: Pharma partners collaborate to federate historical and purpose-built antibody developability data sets for secure ML training, without data leaving each partner’s environment.
About the role
At Apheris, we power federated data network in life sciences to address the data bottleneck in training highly performant ML models. Publicly available, molecular datasets are insufficient to train high-quality ML models that meet industry requirements. Our product addresses this by hostin
Full description, company and the link to apply — after you sign in.
Sign inEmployer contacts (email/phone/telegram) are hidden from the public preview —
send your CV, and we will connect you directly.